Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

National Institute of Environmental Health Sciences

Use this QR code to view the newest version of this document
Use this QR code to view the newest version of this document

Your Environment. Your Health.

Publication Detail

Title: Semicarbazide-sensitive amine oxidase and extracellular matrix deposition by smooth-muscle cells.

Authors: Langford, Shannon D; Trent, Margaret B; Boor, Paul J

Published In Cardiovasc Toxicol, (2002)

Abstract: We have recently reported in vivo disruption of collagen and elastin architecture within blood vessel walls resulting from the selective inhibition of the enzyme semicarbazide-sensitive amine oxidase (SSAO). This study further investigates the effects of SSAO inhibition on extracellular matrix deposition by smooth-muscle cells (SMCs) cultured from neonatal rat hearts. SMCs were characterized, SSAO activity was measured, and soluble and insoluble collagen and elastin in the extracellular matrix (ECM) were quantified. Cultured neonatal rat heart SMC exhibited a monotypic synthetic phenotype that likely represents a myofibroblast. Detectable levels of SSAO activity present throughout 30-d culture peaked at 7-14 d, coinciding with the production of ECM. The addition of enzyme inhibitors and alternate SSAO substrates (benzylamine) produced varied and, in some cases, marked changes in SSAO activity as well as in the composition of mature and soluble matrix components. Similar to our previous in vivo findings, in vitro SSAO inhibition produced aberrations in collagen and elastin deposition by heart SMC. Because changes in SSAO activity are associated with cardiovascular pathologic states, this enzyme may play a protective or modulating role by regulating ECM production during pathologic insult.

PubMed ID: 12271157 Exiting the NIEHS site

MeSH Terms: Allyl Compounds/administration & dosage; Allyl Compounds/antagonists & inhibitors; Allylamine/administration & dosage; Allylamine/analogs & derivatives*; Allylamine/antagonists & inhibitors; Amine Oxidase (Copper-Containing)/antagonists & inhibitors; Amine Oxidase (Copper-Containing)/drug effects; Amine Oxidase (Copper-Containing)/metabolism*; Animals; Cells, Cultured; Collagen/drug effects; Collagen/metabolism; Dose-Response Relationship, Drug; Elastin/drug effects; Elastin/metabolism; Enzyme Inhibitors/administration & dosage; Extracellular Matrix/drug effects; Extracellular Matrix/metabolism*; Models, Animal; Models, Cardiovascular; Monoamine Oxidase Inhibitors/administration & dosage; Myocardium/cytology; Myocardium/metabolism; Myocytes, Smooth Muscle/classification; Myocytes, Smooth Muscle/drug effects; Myocytes, Smooth Muscle/metabolism*; Propylamines/administration & dosage; Propylamines/antagonists & inhibitors; Rats; Rats, Sprague-Dawley; Time Factors

Back
to Top